Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11031650 | Seizure | 2018 | 6 Pages |
Abstract
These preliminary data point to a favorable cognitive profile of BRV similar to its precursor levetiracetam. Objective gains in attention and executive functions were accompanied by self-reported improvements in concentration and comprehension. Future studies with larger sample sizes and better control conditions are needed to confirm these findings.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Juri-Alexander Witt, Christian E. Elger, Christoph Helmstaedter,